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Introduction
Corynebacterium diphtheriae is the etiological agent 
of a serious infectious disease – diphtheria. The diphthe-
ria vaccine is highly effective but is directed only against 
the diphtheria toxin. The non-toxigenic C. diphtheriae 
strains may cause many severe invasive diseases, e.g., 
endocarditis, septic arthritis, bacteremia, and noninva-
sive wound infections. The notified increasing number 
of non-toxigenic C. diphtheriae infections indicates that 
infections are a growing problem in Europe (Belko et al. 
2000; Zasada et al. 2010; Zasada 2013; Fricchione et al. 
2014; Dangel et al. 2018). It is hypothesized that high 
vaccination coverage has resulted in the emergence of 
non-toxin-producing (non-toxigenic) C. diphtheriae 
strains, which acquired new virulence factors.
The diphtheria toxoid vaccination protects against 
the action of the toxin but does not protect against 
colonization and invasion by C. diphtheriae. Little is 
known about C. diphtheriae virulence factors other 
than the diphtheria toxin. The degree of adhesion of 
microorganisms to host cells has been shown to be 
an important pathogenicity factor for both toxigenic 
and non-toxigenic strains (Colombo et al. 2001). The 
virulence factors that facilitate bacterial colonization 
to specific host tissues and are related to pathogenesis 
include pili and fimbriae (Reardon-Robinson and Ton-
That 2014). These structures are covalently attached to 
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A b s t r a c t
The aim of this study was to identify the potential vaccine antigens in Corynebacterium diphtheriae strains by in silico analysis of the amino 
acid variation in the 67–72p surface protein that is involved in the colonization and induction of epithelial cell apoptosis in the early stages 
of infection. The analysis of pili structural proteins involved in bacterial adherence to host cells and related to various types of infections 
was also performed. A polymerase chain reaction (PCR) was carried out to amplify the genes encoding the 67–72p protein and three pili 
structural proteins (SpaC, SpaI, SapD) and the products obtained were sequenced. The nucleotide sequences of the particular genes were 
translated into amino acid sequences, which were then matched among all the tested strains using bioinformatics tools. In the last step, 
the affinity of the tested proteins to major histocompatibility complex (MHC) classes I and II, and linear B-cell epitopes was analyzed. 
The variations in the nucleotide sequence of the 67–72p protein and pili structural proteins among C. diphtheriae strains isolated from 
various infections were noted. A transposition of the insertion sequence within the gene encoding the SpaC pili structural proteins was also 
detected. In addition, the bioinformatics analyses enabled the identification of epitopes for B-cells and T-cells in the conserved regions of 
the proteins, thus, demonstrating that these proteins could be used as antigens in the potential vaccine development. The results identified 
the most conserved regions in all tested proteins that are exposed on the surface of C. diphtheriae cells.
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the bacterial cell wall and are recognized by the related 
host receptors (Sauer et al. 2000; Rogers et al. 2011). The 
surface structures are potential candidates for the devel-
opment of new vaccines and antimicrobial therapies, 
due to their significant role in pathogenesis (Maione 
et al. 2005; Soriani and Telford 2010). Pili are found in 
both Gram-positive and Gram-negative bacteria, albeit 
with different folding mechanisms (Thanassi et al. 1998; 
Ton-That and Schneewind 2004). The function of pili 
is not only the involvement in adhesion, but they also 
act as bacteriophage receptors and participate in DNA 
transfer, biofilm formation, cell aggregation, host cell 
penetration, and motility (Proft and Baker 2009).
There are three types of pili in C. diphtheriae strains 
(SpaA, SapD, and SpaH), each containing the LPXTG 
motif (Ton-That and Schneewind 2003; Gaspar and 
Ton-That 2006; Swierczynski and Ton-That 2006). The 
genes involved in the production of pili encode nine pili 
proteins, defined in the successive letters from SpaA 
to SpaI, and five sortases defined from SrtA to SrtE, 
which are organized in three separate clusters. The sixth 
sortase SrtF (class-D homolog) is now referred to as 
the housekeeping sortase, located in a different region 
of the chromosome (Ton-That and Schneewind 2003). 
C. diphtheriae, like other Gram-positive bacteria (e.g. 
Streptococcus pneumoniae, group A and B streptococci 
or Actinomycetes), have the gene encoding cysteine 
transpeptidase (sortase) conserved in the genome, 
which is necessary for the assembly of pili (Ton-That 
and Schneewind 2004; Marraffini et al. 2006).
Pili are composed of three proteins: the main subu-
nit forming the stem of pili, and two smaller subunits 
located at the base and at the end of the pili, e.g., SpaA-
type pili is structured in such way that the SpaA pili 
protein creates a stem, SpaC is located at the end of pili, 
while SpaB is located along the stem and at the base 
(Ton-That and Schneewind 2003; Mandlik et al. 2008; 
Rogers et al. 2011). SpaA is important for the forma-
tion of the pile structure (Ton-That and Schneewind 
2004). It has been proven that in the absence of SpaA 
protein, SpaB and SpaC are anchored in the cell wall as 
monomers (Mandlik et al. 2007).
The adhesion process of C. diphtheriae strains to the 
surface of human cells is multifactorial. Functions and 
mechanisms of action of fimbriae (Mandlik et al. 2007), 
non-fimbrial 67–72p adhesin (Colombo et al. 2001), 
trans-sialidase (Mattos-Guaraldi et al. 1998), hydro-
phobins, and sugar residues (Mattos-Guaraldi et al. 
1999a; 2000; Moreira et al. 2003) are poorly understood, 
especially how they jointly participate in the adherence 
to the host cells and in the colonization of these cells 
during bacterial infection.
Initially, the 67–72p adhesive protein was described 
as a  ligand responsible for the adherence of C. diph­
theriae to human erythrocytes (Colombo et al. 2001). 
Later, the participation of this protein in the adherence 
of bacteria to HEp-2 cells was described (Hirata et al. 
2004). The presence of the 67–72p protein has been 
confirmed in C. diphtheriae strains isolated from vari-
ous sources, e.g., on the surface of the cells of invasive 
HC01 strain isolated from the blood of a patient with 
endocarditis (Sabbadini et al. 2012).
C. diphtheriae strains exhibit cell surface hydropho-
bicity and autoaggregation. Thanks to these features, 
microorganisms avoid immune defenses and are able 
to survive on the surface of the skin and mucosal mem-
branes (Mattos-Guaraldi et al. 1999b). In addition, it 
has been proven that the 67–72p protein has the ability 
to induce host cell death, giving a signal for apopto-
sis in the early stages of infection. The occurrence of 
67–72p hemagglutinin is one of the characteristics 
of the potentially invasive strains because it can con-
tribute to the cytotoxicity and apoptosis of the infected 
cells (Sabbadini et al. 2012).
In our study, we analyzed the nucleotide and amino 
acid sequences of the genes encoding pili proteins 
which contribute to bacterial adherence to host cells, 
and also the gene encoding 67–72p protein involved 
in adhesion, colonization, and induction of the cell 
apoptosis in the early stage of infection, which should 
be used in a preliminary research for the finding of new 
vaccine antigens.
Experimental
Materials and Methods
Bacterial strains. In total, 10 C. diphtheriae non-
toxigenic isolates were used in this study (Table  I). 
Strains were isolated in Poland in 2010–2017 from 
patients with bacteremia, wound infection, septic arthri-
tis, endocarditis, and serous cyst contents. The strain 
NCTC 13129 was used as the control strain.
27/E mitis Serous cyst contents 2010
40/E gravis Blood 2014
68/E gravis Endocarditis 2015
71/E gravis Wound 2015
73/E gravis Blood 2016
77/E gravis Wound 2016
78/E gravis Blood 2016
79/E gravis Blood and joint fluid 2016
86/E gravis Blood 2017
89/E gravis Wound 2017
Table I
C. diphtheriae strains used in this study.
Strain Biotype Site of isolation Year of isolation
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DNA isolation. C. diphtheriae strains were grown 
on Columbia agar with 5% sheep blood (BioMerieux) 
for 24 h at 37°C under aerobic conditions. Genomic 
DNA was isolated using a Wizard Genomic DNA Puri-
fication Kit (Promega) according to the Gram-positive 
bacteria procedure provided by the manufacturer.
Polymerase Chain Reaction (PCR). The oligo-
nucleotide primers for amplification of the genes cod-
ing 67–72p protein and structural pili proteins (SpaC, 
SpaI, SapD) were designed based on the nucleotide 
sequence of the C. diphtheriae NCTC 13129 whole 
genome, available from GenBank under the number 
BX248353 (Table II).
The PCR reaction was conducted in a total volume of 
25 μl and the reaction mixture contained 0.5 μl genomic 
DNA, 12.5 μl HotStarTaq Master Mix (Qiagen), and 1 μl 
of 10 μM solution of each primer (Table II). The cyc- 
ling conditions were as follows: initial denaturation at 
95°C/10 min and 29 cycles of denaturation at 94°C/ 
1 min, primer annealing at 52°C/45 s, primer extension 
at 72°C/1 min and a final elongation at 72°C/10 min.
The PCR products were enzymatically cleaned using 
an Exo-BAP Mix kit (EURx), according to the manufac-
turer’s procedure and then sent for sequencing.
Sequencing of fragment 4 of the gene encoding 
SpaC protein in strain 89/E. Based on the result of the 
67–72p 6772p1L TGAAAAATAATTTAAGGAGTTCCAA 
695 bp
 6772p1R CAACCCACCAGTAACAGCAA
 6772p2L CTGTTTTGCTGGTCGTAGCA 
841 bp
 6772p2R ACCTCATCAACCTGGTTTGC
 6772p3L GAATCGTTGCAGCCCAAG 
699 bp
 6772p3R CCTTAAGCACTGGGTCGTTT
 6772p4L CACCGACAACGTTGGTTACA 
844 bp
 6772p4R TTCTGGCTTGTCCCTGTTCT
 6772p5L TCAAGCCGGAGTCCCAGA 
692 bp
 6772p5R TCAGTTGTGTCTGGTGAAAGG
spaI SpaI1L GCGGAATCAACACCAACAC 
600 bp
 SpaI1R AAGCGCTTACGATCCAAGAA
 SpaI2L ACACGGCCTTCCAAACTTC 
482 bp
 SpaI2R TGATATTGAGGCGTCGCTAA
sapD SapD1L TCGCGAAGGTAAGAAATACTCA 
698 bp
 SapD1R CGTTTGTATCCGAGCCACTT
 SapD2L GTCCAAAACAAGAGCGGAAA 
814 bp
 SapD2R GGTTCAGTGAAAACCCAGTTG
spaC SpaC1L GCCTACTCTCACTGGCAAGG 
824 bp
 SpaC1R ACATGGCGATCTCCTGAAGT
 SpaC2L TCGTGCAGGACGTACCAATA 
838 bp
 SpaC2R AACTGCACTGTGACCGAAAA
 SpaC3L GGCATCATAAAGTGCAATCG 
808 bp
 SpaC3R TCACGTTGAGTTCTTCGTTCA
 SpaC4L CATTCGTTTTTGTTCCGTGA 
850 bp
 SpaC4R GGTGTAGAAACGCCTCGAAA
 SpaC5L CCAAATTCAACAGTTTGATTATCACT 
850 bp
 SpaC5R TTCCTGTCACTTACACCTGTCG
 SpaC6L CAAAATACGGATTGGTTTCTGG 
845 bp
 SpaC6R AGCTGGCTGGAATTTCGAT
 SpaC7L CAAAGGTGTCTTGGCCATTT 
687 bp
 SpaC7R TCACGCCAGTAAGTCTTGCTAA
 SpaC8L CTGGCATCTGGATGTCATTG 
578 bp
 SpaC8R ACCGAACGTGCCTAGCGTA
Table II
Primers used in this study.
Gene Primer Sequence Length of the amplifiedfragment
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first round of sequencing, new primers were designed 
to completely sequence a fragment of approximately 
2000 bp, as follows: SpaC4L 5’-CATTCGTTTTTGTT 
CCGTGA-3’ and SC1pR 5’-GAGCTGCTTGAAGTT 
GCAGA-3’ (391 bp), SC2pL 5’-CCCGAACACGTTTG 
GTAAGT-3’ and SC2pR 5’-GGGTAGTGGGTCAGGG 
TTTT-3’ (687 bp), SC3pL 5’-CGCACACAATCAGTGA 
CTAAAA-3’ and SC3pR 5’-ACAACGTATTCGCAGCA 
GTG-3’ (850 bp), SC4pL 5’-ATGGTTATCGCCGTATC 
TGG-3’ and SpaC4R 5’-GGTGTAGAAACGCCTCGA 
AA-3’ (764 bp). The PCR reaction was carried out accor- 
ding to the above conditions, the PCR products were 
then enzymatically purified and sent for sequencing.
Comparing the sequenced fragments and the 
trans lated nucleotide sequences for proteins. The 
sequences of the particular gene fragments were obta i-
ned as fluorograms. The BioEdit program was used for 
the gene assembly, alignment of sequences and compar-
ative calculations. The translation of DNA into protein 
sequences was performed using the BLASTx program.
Analysis of 67–72p, SpaC, SpaI and SapD protein 
affinity to MHC classes I and II and linear epitopes. 
Amino acid sequences of C. diphtheriae NCTC 13129 
reference strain available from the National Center for 
Biotechnology Information (NCBI) were used for analy-
sis. To predict the cellular localization of the proteins, 
the software packages CELLO v.2.5 (Yu et al. 2006) and 
PSORTb version 3.0.2 (Yu et al. 2010) were used. The 
analysis for the transmembrane domains was performed 
using TMHMM Server v. 2.0. The MHC classes I and II 
binding prediction was performed using the immune 
epitope database (IEDB) (Kim et al. 2012) for the recom-
mended human leukocyte antigen (HLA) allele set (Bui 
et al. 2005; Nielsen et al. 2003). Analysis has also been 
carried out using Propred-I (for MHC class I) and Pro-
pred (for MHC class II) regarding the number of alleles 
for which epitopes were found in the proteins analyzed 
(Singh and Raghava 2001; 2003). The prediction of 
linear B-cell epitopes has been carried out using the 
Bepipred Linear Epitope Prediction 2.0 (Jespersen et al. 
2017). VaxiJen 2.0 was used for prediction of the protec-
tive antigens. The results page on VaxiJen server creates 
lists of the selected target, the protein sequence, its pre-
diction probability, and a statement of protective anti-
gen or non-antigen, according to a predefined cut-off. 
Since more of the models had their highest accuracy at 
a threshold of 0.5, this threshold value was chosen for all 
bacterial models types (Doytchinova and Flower 2007).
Results
The isolates from invasive diseases and wound infec-
tions were included in the study because a wound can 
be a portal of entry for invasive infections. Moreover, 
future vaccines against non-toxigenic C. diphtheriae 
should protect against all kinds of infections. The 
analyses conducted in this study showed the variabil-
ity of C. diphtheriae strains in terms of the nucleotide 
sequence of the genes encoding the 67–72p protein 
(99.37–100% average similarity) and structural proteins 
of pili SpaC (38.94–99.97% average similarity), SpaI 
(81.39–100% average similarity), and SapD (63.78–100% 
average similarity). The 27/E strain, the only representa-
tive of the mitis biotype, was the most different from the 
other strains tested. This strain did not have the gene 
coding for the SpaI protein, while the average similari-
ties of the nucleotide sequence of genes encoding the 
67–72p, SapD, and SpaC proteins were 99.37%, 98.64%, 
and 38.94%, respectively when compared to the refer-
ence strain. Despite the significant variation, we man-
aged to locate two fragments of the 67–72p protein 
(fragments No. 3 and 5), where the nucleotide sequences 
were 100% identical for all C. diphtheriae strains tested 
(the most conserved in the genome). In contrast, for 
C. diphtheriae biotype gravis we found as many as nine 
fragments located in the sequence of the gene encoding 
67–72p protein (fragment No. 1, 3, 5) and the genes cod-
ing for the pili SapD (fragment No. 1), SpaI (fragment 
No. 2), and SpaC (fragment No. 2, 3, 7, 8), which were 
100% identical in all nine strains tested (Table III).
The nucleotide sequences of the genes investi ga-
ted were translated into the amino acid sequences. 
We revealed that the identified mutations resulted in 
a reading frame shift or were synonymous and nonsyn-
onymous substitutions (Table IV).
In addition, we observed that a fragment of 1380 bp 
was inserted in the place of the gene encoding the SpaC 
protein in the 89/E strain (Table III). After sequenc-
ing the fragment No. 4 of spaC, we obtained the exact 
nucleotide sequence, which we compared to the avail-
able sequences in the GeneBank using the Nucleotide 
Basic Local Alignment Search Tool (BLASTn). In this 
way, we proved that the 1380 bp insertion sequence (IS) 
was transposed, which interrupted the continuity of the 
tested gene between 3072 bp and 3073 bp of the refer-
ence sequence of the NCTC 13129 strain. The result 
from the BLAST search revealed that the insertion frag-
ment we detected was similar to the sequence of IS3 
family transposase also identified in other C. diphthe­
riae strains but in different locations.
Analysis of the 67–72p, SpaC, SpaI and SapD pro-
tein affinity to MHC classes I and II, and linear B-cell 
epitopes in the first stage relied on the determination 
of the position of the proteins tested in the cell mem-
brane and confirmation that all selected proteins were 
at least partially membranous or extracellular (Table V). 
Then, using the IEDB platform, it was observed that 
all proteins have high-affinity areas for MHC receptors 
of both classes and the fragments, which can be recog-
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nized by antibodies. The output for the prediction of the 
high- affinity MHC binding peptides is typically given 
either in the units of a predicted affinity (IC50 nanomo-
lar) or as a percentile score reflecting the relative affin-
ity of a selected peptide compared with a universe of 
random sequences. According to Paul et al. (2013), 
there are four categories of percentile ranks: 1) 0–0.30; 
2) 0.30–1.25; 3) 1.25–5.0; and 4) 5.0–15.0. Their study 
proved that four pools of predicted peptides derived 
from the first two categories (0–0.30; 0.30–1.25) were 
immunogenic but finally, the transgenic mice in their 
study recognized only one peptide pool from the first 
category (0–0.30) (Paul et al. 2013). We can say that 
the smaller the percentile rank value, the higher the 
affinity. As for the IC50 value, according to the IEDB 
Solutions Centre guidelines, IC50 < 50 designs very high 
affinity, IC50 < 500 – high affinity, and IC50 < 5000 means 
low affinity (Fleri 2013). Accepting even the thresh-
old of cutting off the percentile rank below 1 or IC50 
below 50, we still could have at least 100 to several hun-
dred regions with high affinity for each of the proteins 
(Table VI, Table VII).
Table VIII contains data on the number of alleles for 
which epitope that was found in the proteins analyzed. 
Overall, 40 HLA alleles of human origin encoded by 
HLA-A and HLA-B were selected for ProPred1. The 
HLA 7 from mouse s-derived (MHC-Db, MHC-Db 
revised, MHC-Dd, MHC-Kb, MHC-Kd, MHC-Kk, 
67–72p 1  98.35 100 100 100 100 100 100 100 100 100
 2  99.5 100 100 100 100 100 100 100 100  99.87
 3 100 100 100 100 100 100 100 100 100 100
 4  99.01 100 100 100 100 100 100 100  97.90  97.90
 5 100 100 100 100 100 100 100 100 100 100
SapD 1  98.91 100 100 100 100 100 100 100 100 100
 2  98.37  27.52 100 100 100 100 100 100  99.86  99.86
SpaI 1   – 100 100 100 100 100 100  62.77 100 100
 2   – 100 100 100 100 100 100 100 100 100
SpaC 1  72.78  99.87  99.87  99.87  99.87  99.87  99.87  99.87  99.87  99.87
 2  97.11 100 100 100 100 100 100 100 100 100
 3   – 100 100 100 100 100 100 100 100 100
 4   – 100 100 100 100 100 100 100  99.75  IS*
 5  91.47  99.21 100 100  99.87 100 100 100 100 100
 6   – 100 100 100 100 100  99.87  99.87 100 100
 7  50.16 100 100 100 100 100 100 100 100 100
 8   – 100 100 100 100 100 100 100 100 100
Table III
Comparison of the nucleotide sequences of all strains tested against the reference strain, given in percent (%).
The sequences are presented according to the analysed fragments.
* – In the fragment 4 of the gene encoding SpaC protein, the insertion sequence has been transposed
Target
protein Fragment 27E 40E 68E 71E 73E 77E 78E 79E 86E 89E
67–72p 99 100 100 100 100 100 100 98 98 100
SapD 97 99 100 100 100 100 100 100 99 99
SpaI – 100 100 100 100 100 100 84 100 100
SpaC 48 99 99 99 69 99 69 69 69 51
Table IV
Comparison of amino acid sequences of all strains tested against the reference strain, given in percent (%).
Target
protein 27E 40E 68E 71E 73E 77E 78E 79E 86E 89E
Start 44 138 235 310 36 1 1
Stop 57 169 257 987 1845 236 631
Table V
Extracellular regions of individual proteins.
*Amino acid positions
Region* 67–72p SpaC SpaI SapD
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and MHC-Ld) was omitted. The Proteasome Filter and 
Immunoproteasome filters were included in the analy-
sis and for both, the threshold score of 4% was used. The 
ProPred1 cut-off threshold was also set at 4%. At the 
ProPred, 51 alleles related to MHC class II were con-
sidered. These were HLA-DR alleles. These molecules 
were encoded by DRB1 and DRB5 genes containing 
HLA DR1 (2 alleles), DR3 (7 alleles), DR4 (9 alleles), 
67–72p HLA-A*02:06 6 14 FTNDRFWSV 0.06
67–72p HLA-B*44:02 34 42 SENDSSVEY 0.06
67–72p HLA-A*30:02 68 77 RMASYWLDRY 0.06
67–72p HLA-B*44:02 9 17 AEALSQVGI 0.07
67–72p HLA-A*02:06 27 36 MILGALVPTV 0.07
67–72p HLA-A*68:01 1 9 YAFTLPALR 0.11
67–72p HLA-A*01:01 43 51 DTDSSTYTY 0.11
67–72p HLA-A*01:01 48 56 YTTLTSLPY 0.11
67–72p HLA-B*44:03 34 42 SENDSSVEY 0.11
67–72p HLA-B*57:01 58 66 SSLAIGNAW 0.12
SapD HLA-B*44:03 65 74 AEWQELDTWW 0.06
SapD HLA-B*07:02 4 13 RPIWAGIGAF 0.11
SapD HLA-B*44:03 28 36 KEGAYGLEY 0.11
SapD HLA-A*68:01 47 55 NVFFKNNSR 0.12
SapD HLA-B*40:01 10 18 IEAQISGSL 0.17
SapD HLA-A*24:02 70 79 VWYAPQNIPF 0.18
SapD HLA-A*68:01 24 32 DTVGSESAR 0.2
SapD HLA-B*51:01 50 58 YPLHISYLV 0.2
SapD HLA-A*68:01 41 50 EPAFGVTIPK 0.22
SapD HLA-A*68:01 17 26 EAYVKNGAFK 0.26
SpaC HLA-A*11:01 658 666 STNSVWIPK 0.06
SpaC HLA-A*01:01 220 229 LSDDKPFDLY 0.07
SpaC HLA-B*53:01 233 241 LPSEDDYYW 0.1
SpaC HLA-A*68:02 191 199 EVVELENAV 0.1
SpaC HLA-A*02:06 1859 1867 LVAAALWLV 0.11
SpaC HLA-A*23:01 88 96 PYRFGIYTF 0.11
SpaC HLA-A*68:01 1436 1444 NTTYSITYK 0.11
SpaC HLA-A*31:01 363 371 RFKNARCQR 0.11
SpaC HLA-B*44:02 1054 1063 AENTLSADAI 0.11
SpaC HLA-A*23:01 1578 1587 SYTCTMPHLF 0.12
SpaI HLA-A*30:01 2 11 KKTHLFRIPA 0.08
SpaI HLA-B*07:02 9 17 IPAATTAAV 0.1
SpaI HLA-B*07:02 147 155 RPAEYRRTL 0.1
SpaI HLA-B*57:01 109 117 RSRLSDEVW 0.12
SpaI HLA-A*30:02 129 137 VTGLPMGVY 0.18
SpaI HLA-A*02:01 137 145 YLVSETPPA 0.2
SpaI HLA-A*02:03 20 29 LLASGPIASA 0.2
SpaI HLA-A*02:06 153 161 RTLDFLITV 0.21
SpaI HLA-B*51:01 196 205 FPPVESSVTL 0.24
SpaI HLA-A*68:01 252 261 LAIAGFLVQR 0.32
Table VI
MHC class I epitopes predicted from the target proteins.
MHC I
Target
protein Alleles Start End Peptide
Percentile
rank
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67–72p HLA-DRB3*01:01 660 674 DGSVDLYEFDENDPV 0.01
67–72p HLA-DRB3*01:01 713 727 MLARYHVDDARDFFT 0.01
67–72p HLA-DPA1*03:01/DPB1*04:02 15 29 PQRRLTWLIPLLMIL 0.01
67–72p HLA-DPA1*03:01/DPB1*04:02 173 187 STFSVLLVVAFLIAL 0.01
67–72p HLA-DRB1*07:01 49 63 VDFRGVFNKVIATRI 0.01
67–72p HLA-DPA1*01/DPB1*04:01 165 179 LPALRLVVSTFSVLL 0.01
67–72p HLA-DPA1*01/DPB1*04:01 267 281 VISAVVAISFFSVIV 0.01
67–72p HLA-DRB1*09:01 100 114 PVVQYRAAVEKGVHR 0.02
67–72p HLA-DRB3*01:01 712 726 KMLARYHVDDARDFF 0.02
67–72p HLA-DPA1*01:03/DPB1*02:01 172 186 VSTFSVLLVVAFLIA 0.02
SapD HLA-DRB3*01:01 181 195 GKDSIPEHLDKNMYF 0.01
SapD HLA-DRB1*03:01 531 545 PLHISYLVGDATIAR 0.03
SapD HLA-DQA1*04:01/DQB1*04:02 535 549 SYLVGDATIARAKEI 0.09
SapD HLA-DRB1*03:01 444 458 PSDALLPDSKMTVSL 0.12
SapD HLA-DQA1*03:01/DQB1*03:02 616 630 VQDEAVTTAAEWQEL 0.13
SapD HLA-DRB1*03:01 442 456 DLPSDALLPDSKMTV 0.13
SapD HLA-DQA1*03:01/DQB1*03:02 615 629 DVQDEAVTTAAEWQE 0.16
SapD HLA-DRB5*01:01 640 654 LLGILGIVGAFVLFR 0.24
SapD HLA-DQA1*04:01/DQB1*04:02 537 551 LVGDATIARAKEILA 0.27
SapD HLA-DRB1*03:01 346 360 TGTPKTIINDGHMDL 0.29
SpaC HLA-DRB3*01:01 157 171 NDIDRGIKYDAVYFI 0.01
SpaC HLA-DRB3*01:01 505 519 DNGTYRFKADTDAFK 0.01
SpaC HLA-DRB3*01:01 1427 1441 EHSVDPWLLNTTYSI 0.01
SpaC HLA-DRB3*01:01 1699 1713 VVINNVYTTDAEINI 0.01
SpaC HLA-DRB3*01:01 1804 1818 EVTLDNYDADSGLIT 0.01
SpaC HLA-DRB3*01:01 1450 1464 IKDRSYSNDVDIQAD 0.02
SpaC HLA-DRB1*03:01 769 783 AGDIVKVVVDNTAKR 0.03
SpaC HLA-DRB1*09:01 1845 1859 NGYLRWLLAGAAGLL 0.04
SpaC HLA-DPA1*03:01/DPB1*04:02 21 35 LAMVMSIVLVPLIAA 0.05
SpaC HLA-DRB3*01:01 1432 1446 PWLLNTTYSITYKCD 0.07
SpaI HLA-DRB3*01:01 147 161 RPAEYRRTLDFLITV 0.07
SpaI HLA-DRB1*08:02 3 17 KTHLFRIPAATTAAV 0.18
SpaI HLA-DRB3*01:01 151 165 YRRTLDFLITVPAGM 0.19
SpaI HLA-DPA1*01/DPB1*04:01 248 262 LGIALAIAGFLVQRR 0.28
SpaI HLA-DRB3*01:01 43 57 ISDIRCDTGSLTLIK 0.29
SpaI HLA-DRB5*01:01 155 169 LDFLITVPAGMRTAD 0.42
SpaI HLA-DRB1*09:01 95 109 AGWDAAKALTIQEAR 0.44
SpaI HLA-DRB1*11:01 50 64 TGSLTLIKRPPAAFE 0.44
SpaI HLA-DQA1*01:02/DQB1*06:02 242 256 VLGIAALGIALAIAG 0.48
SpaI HLA-DPA1*02:01/DPB1*05:01 150 164 EYRRTLDFLITVPAG 0.6
Table VII
MHC class II epitopes predicted from the target proteins.
MHC II
Target
protein Alleles Start End Peptide
Percentile
rank
DR7 (2 alleles), DR8 (6 alleles), DR11 (9 alleles), DR13 
(11 alleles), DR15 (3 alleles), and DR51 (2 alleles). The 
cut-off threshold was set at 3%.
The target protein sequences were scanned for 
B-cell epitopes using the Bepipred Linear Epitope Pre-
diction 2.0. The selected B-cell linear epitopes of the 
proteins analyzed are shown in Table IX.
The results obtained with the VaxiJen server also 
confirmed the possibility of using the proteins as anti-
gens in vaccines (Table X).
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Table IX
B-cell epitopes predicted from the target proteins.
6772p 1 4 20 GFTRPAAAPKRPQRRLT 17
6772p 2 48 53 EVDFRG 6
6772p 3 87 111 GRPDELEFFDPDSPVVQYRAAVEKG 25
6772p 4 143 156 NRQDFGVSDQQFGM 14
6772p 5 194 211 GGIRAGNQAAGVKGSITN 18
6772p 6 281 287 VTKDLRI 7
6772p 7 316 329 SPNRAEKESEYISR 14
6772p 8 337 369 AYGITDDAVTYKDNWGAKGASSEKVASDSATVS 33
6772p 9 381 410 PTFTQQQQLRNFYGFPKSLAMDRYVIDGEL 30
6772p 10 421 434 DPNALKENQRDWIN 14
6772p 11 452 467 QVDEVARDVGSARGGY 16
6772p 12 474 490 DLQTTDKEAQELGIVVK 17
6772p 13 498 507 PVIASATDGA 10
6772p 14 514 541 SENDSSVEYDTDSSTYTYQGKGGVNIGN 28
6772p 15 562 566 RVNGN 5
6772p 16 573 581 RDPRERVHN 9
6772p 17 612 645 TSLPYAERTSLSEATNDTTAQVGNSAQRLVTDNV 34
6772p 18 680 705 GVFPGTVKAKSEISEELMNHLRYPED 26
6772p 19 714 749 LARYHVDDARDFFTNDRFWSVPSDPSATEGQKDVAQ 36
6772p 20 760 763 DTGK 4
6772p 21 773 777 RGLQR 5
6772p 22 803 837 TDTLTQGPKQAQDTMMSSDQIASDRTLWKDTNDLF 35
6772p 23 861 868 RKNQASAF 8
6772p 24 896 944 GIDPKEAQDLGEAKGLKPESQNRDKPEDKEGKAPSTPSAPASGSGTTGE 49
6772p 25 956 976 LQSAKNGSNEEYGRALDELDK 21
SpaC 1 38 49 ANAEPLPKKEFE 12
SpaC 2 64 69 SLSASD 6
SpaC 3 100 113 SPAAGNKNFTPVSL 14
SpaC 4 131 146 MPAIRENKKGSPNGGT 16
SpaC 5 176 184 PTWDNNGRN 9
SpaC 6 225 228 PFDL 4
SpaC 7 231 234 PILP 4
SpaC 8 246 254 WKIDRSLTG 9
SpaC 9 324 332 PSIETDKNG 9
SpaC 10 355 358 TGDQ 4
SpaC 11 371 387 RYSYGQAPTDIPIKTSD 17
SpaC 12 417 432 KVNVNTPQLLEELNNQ 16
Target
protein No. Start End Peptide Length
67–72p 40 100 51 100
SpaC 37  92.5 51 100
SpaI 34  85 50 98
SapD 33  82.5 51 100
Table VIII
Number of alleles for which epitopes were found in the proteins tested.
Target
protein
Number of MHC alleles
of class I (per 40)
% Bound alleles
MHC class I
Number of MHC
alleles of class II (per 51)
% Bound alleles
MHC class II
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SpaC 13 455 468 GVHNGESKEIGKVA 14
SpaC 14 478 507 VTPKVDDSRMKLSTTWSSENTTADANQDNG 30
SpaC 15 512 522 KADTDAFKNKK 11
SpaC 16 531 537 NYEAQTA 7
SpaC 17 545 561 IINRDKIPATKLPEKFP 17
SpaC 18 569 591 VPHPNARPEHGGLPETNPYFVDS 23
SpaC 19 601 610 SIEIGPFPVG 10
SpaC 20 619 659 ARLDPNVQADAKIPGFSLKTEWNSNICFGNTIDNNSQDCST 41
SpaC 21 664 672 IPKPGQYSL 9
SpaC 22 676 684 NTYTRELAS 9
SpaC 23 690 702 TVSGDASDLTNSH 13
SpaC 24 712 731 DSGVEVYSQDNIVVKKDGRQ 20
SpaC 25 746 754 EKQPEQKGV 9
SpaC 26 761 769 PFHLRASTA 9
SpaC 27 779 786 NTAKRQVA 8
SpaC 28 792 812 KKVHKKDTFSPEISASIDALT 21
SpaC 29 819 846 CTVPGVETPRKVLKTVSDNQTVEFGNFP 28
SpaC 30 857 861 TEAPA 5
SpaC 31 881 885 TPINK 5
SpaC 32 891 895 FENAR 5
SpaC 33 904 948 VLDGDMPQALVDQIPSSFTVNVACSITGNHSITLQKDEQKAVPGV 45
SpaC 34 957 968 SEEVTPITGATH 12
SpaC 35 971 991 HWIKGELLEVADSTDITINPN 21
SpaC 36 1001 1007 HYETDAV 7
SpaC 37 1012 1037 TKRVRVIDQVGNDVNSELKNAVVRPE 26
SpaC 38 1043 1052 RYRCEINGQV 10
SpaC 39 1059 1073 SADAINTGATKVPRG 15
SpaC 40 1079 1131 EEDSSSVELSNATLSHVEFFVHGTKTNDKASVAINSDHNRLDATNTFTLKTGS 53
SpaC 41 1135 1146 KKKVDGEGVSTI 12
SpaC 42 1157 1164 RCTLGDWK 8
SpaC 43 1174 1188 FDSAESHSVKDIPVG 15
SpaC 44 1195 1204 EDSEKAQEPN 10
SpaC 45 1210 1240 RWTHTDSTNGWGDTEAACENHAACEVDPKNE 31
SpaC 46 1250 1255 NEKENF 6
SpaC 47 1276 1288 KVLTNDGPELAGK 13
SpaC 48 1298 1346 TDPRFAGSDLADKHSIPDPTITVALNAKGQSRASYQVADERHDSVEVPV 49
SpaC 49 1357 1360 IALY 4
SpaC 50 1378 1401 AVQRTSSNSASARFVTEKQENNGT 24
SpaC 51 1409 1413 DYIRP 5
SpaC 52 1424 1437 AKPEHSVDPWLLNT 14
SpaC 53 1443 1483 YKCDDPYIKDRSYSNDVDIQADAEKPTPIFADPTAHVKIPA 41
SpaC 54 1492 1498 NTEGHLP 7
SpaC 55 1506 1555 DETNKVAEFAGEHEKRSYFTPEIKDVVLSESEPTRIEFTNSYVMPQRILS 50
SpaC 56 1560 1569 VEGDPGHAVI 10
SpaC 57 1582 1605 TMPHLFPNQPNPMSQEVGNKVARG 24
SpaC 58 1614 1622 TWRSPEVPI 9
SpaC 59 1630 1643 EEDDPALRTKLENN 14
SpaC 60 1645 1687 LRMVPTYLFPTERAGAASAPVIPPLTDRPIYNGTEPRLQMPES 43
Table IX. Continued.
Target
protein No. Start End Peptide Length
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Table IX. Continued.
Target
protein No. Start End Peptide Length
SpaC 61 1718 1723 ADNSPL 6
SpaC 62 1734 1755 GENGQRKELPEVADAPAKSAKS 22
SpaC 63 1808 1825 DNYDADSGLITVEHPQGK 18
SpaC 64 1837 1842 STLPLT 6
SapD 1 23 72 PVSASEDAALDATGHKKGEPAFGVTIPKGTTYRDSDGKEVPHPCVDRKIG 50
SapD 2 86 96 YSVKEPATDLP 11
SapD 3 104 113 DGQQVVPQES 10
SapD 4 122 145 AGEDGEELSRIRIPDDEEFSFLGK 24
SapD 5 157 162 IPFANG 6
SapD 6 174 190 DPHHEPKGKDSIPEHLD 17
SapD 7 224 234 SNDEELKTIEY 11
SapD 8 264 269 AFKVKT 6
SapD 9 281 350 DEEVGLPEGTTTNLNKITKPLDKDATNEPPTDPSEKKKPPRPEKGHSETSSPSA 70
    LDDSIERAWKLTGTPK
SapD 10 371 380 TVINREGKKY 10
SapD 11 392 418 SGGDQGGPLVKTDSWKDRIEAQISGSL 27
SapD 12 441 451 EDLPSDALLPD 11
SapD 13 525 529 GKQES 5
SapD 14 542 606 TIARAKEILAGEKLGGSLKKKPQEKETKKPASVQNKSGKHNKDTVGSESARK 65
    RQQLAATSGSDTN
SapD 15 624 632 AAEWQELDT 9
SpaI 1 22 50 ASGPIASADSRTITGATDGLNISDIRCDT 29
SpaI 2 55 75 LIKRPPAAFEGVDKADLPAGT 21
SpaI 3 86 124 IEGIDLTKQAGWDAAKALTIQEARSRLSDEVWKAVSGRD 39
SpaI 4 144 153 PAKRPAEYRR 10
SpaI 5 166 174 RTADGNVAS 9
SpaI 6 186 242 TDDLPPTVPVFPPVESSVTLTPSSPVPGTPKTPGKPDLPEKFRKEVTDRLGNT 57
    GANV
SpaI 7 263 266 KKNE 4
6772p 0.5123
SpaC 0.6757
SpaI 0.5504
SapD 0.5544
Table X
Prediction of the protective antigens from the VaxiJen server.
Protein Overall Prediction for the Antigen
Discussion
The huge success of vaccination against diphtheria 
almost enabled the elimination of the disease in Europe 
and other developed countries. However, in many coun-
tries with high vaccination coverage, i.e. France, Italy, 
Switzerland, Germany, and Canada an increase in non-
toxigenic C. diphtheriae infections has been observed. 
For example, Poland is a country where the last case of 
diphtheria was recorded in the year 2000 and where the 
vaccination level of over 95% is achieved (Zasada et al. 
2010). The first case of non-toxigenic infection with 
C. diphtheriae biotype gravis was recorded in Poland in 
2004, where this bacterium induced sepsis and endo-
carditis in a patient (Zasada et al. 2005) and since then, 
practically every year, several cases of invasive C. diph­
theriae infections have been diagnosed. In northern 
Germany, the number of non-toxigenic C. diphtheriae 
infections increased from five in 2013 to 23 in 2016, 
and 24 in only the first half of 2017 (Dangel et al. 2018). 
In England and Wales, a dramatic increase in infections 
was recorded since 1986, peaking at almost 300 cases 
in the year 2000 (Edwards et al. 2011). These examples 
indicate that the development of a new vaccine against 
non-toxigenic C. diphtheriae infection is of very impor-
tant and necessary demand.
In vaccine development, the potential virulence fac-
tors exposed on the surface of a pathogen are considered 
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as suitable antigens for an effective acellular vaccine. It 
has been shown that pili of Gram-positive bacteria play 
a direct role in the pathogenesis. For example, studies 
on S. pneumoniae have proved that those strains, which 
have a pili island, adhere better to lung epithelial cells 
than do the strains that lack this island. In the inva-
sive disease model, the piliated strain is more virulent 
and has a competitive advantage over the pili-negative 
strain after the mixed intranasal infection. Infection 
with the piliated strain induces a stronger inflamma-
tory response and a higher level of the tumor necro-
sis factor in the bloodstream of mice, which may be 
due to the higher adhesion of the piliated bacteria to 
the cells involved in the innate immune response and 
their detection by host cell pattern-recognition recep-
tors (Barocchi et al. 2006). The pili proteins are used 
as antigens in vaccines, for example in some acellular 
pertussis vaccines (Mosley et al. 2016).
The adhesion of Corynebacterium to host cells was 
observed for the first time for C. renale pili, which 
caused agglutination of trypsinized sheep red blood 
cells (Honda and Yanagawa 1974). It was not until 
more than thirty years later that Mandlik and collea- 
gues identified adhesins, which were involved in adher-
ence to pharyngeal host cells – the minor pilins SpaB 
and SpaC of C. diphtheriae (Mandlik et al. 2007). Subse-
quent studies showed that wild type C. diphtheriae cells 
bind to human lung epithelial, laryngeal, and pharyn-
geal cells, whereas mutants that lacked SrtA (i.e. they 
did not polymerize the SpaA-type pili) showed more 
than a 90% lower ability to adhere to human pharyngeal 
cells. Moreover, mutants that lacked only the major pili 
subunit, SpaA, showed a 10% reduction in adherence 
to these cells. In contrast, mutants that lacked either 
of the minor pilin subunits, SpaB or SpaC, showed 
a 70–75% reduction in adhesion. In addition, the latex 
beads coated only with SpaB or SpaC were sufficient 
to adhere to the host pharyngeal cells, while the SpaA-
coated beads did not bind. SpaB and SpaC are anchored 
in the cell wall as monomers independent of the pilus 
structures. It is likely that the long pili mediate the ini-
tial attachment, while the monomeric pilins on the sur-
face of the bacteria participate in the formation of an 
adhesion zone allowing the delivery of toxins and other 
virulence factors and may even play a significant role 
in host cell signaling (Rogers et al. 2011).
In addition to pili, C. diphtheriae produces the 
67–72p protein located on its surface, which is involved 
in colonization, induction of apoptosis, and epithelial 
cell necrosis that were once attributed exclusively to the 
action of the diphtheria toxin (Sabbadini et al. 2012). 
This finding was also confirmed by Cerdeño-Tárraga 
et al. (2003) who sequenced the genome of the Brit-
ish clinical isolate (strain NCTC13129 biotype gravis 
– used in our study as the reference strain) and proved 
that the recent acquisition of pathogenicity factors went 
beyond the toxin itself and included the fimbrial pro-
teins and adhesins. The 67–72p can act as an invasive 
and apoptotic protein for C. diphtheriae strains. The 
ability to penetrate, survive and induce apoptosis in epi-
thelial cells may explain the endurance and dissemina-
tion of C. diphtheriae (Sabbadini et al. 2012). Proteins, 
which act as adhesins were also detected among other 
bacteria, e.g., the occurrence of the extracellular Eap 
protein was confirmed to be involved in colonization of 
eukaryotic cells by S. aureus strains (Haggar et al. 2003).
Our research is based on reverse vaccination. This 
method relies on the sequencing of pathogen genomes 
and determination in silico the most likely protective 
antigens prior to conducting experiments to prove this. 
Originally, this method was used to identify antigens 
as probable candidate vaccines against serogroup  B 
meningococci (Christensen et al. 2013). In another 
study, Droppa-Almeida et al. (2018) used several 
available bioinformatics tools to design the efficient 
immunodominant epitopes for the development of 
the peptide vaccine against C. pseudotuberculosis for 
sheep and goats. Thanks to this research, it was possi-
ble to highlight the importance of bioinformatics soft- 
ware in the design of vaccines, especially in the iden-
tification of appropriate vaccine candidates, immune-
informatics analysis and design of peptide vaccine from 
multi-epitopes (Droppa-Almeida et al. 2018). Bioinfor-
matics tools present a lot of advantages, such as speed 
and low cost, so we used them at particular stages of 
the research.
First, we selected the gene encoding the 67–72p 
protein and the three pili genes spaC, sapD and spaI as 
the genes most frequently detected in various C. diph­
theriae isolates as it was reported in our previous study 
(Zasada et al. 2012). In the present study, we found 
two fragments of 594 bp and 215 bp in the nucleotide 
sequence of the gene coding for the 67–72p surface 
protein, which were identical in all analyzed strains of 
C. diphtheriae, and in total, nine identical in C. diph­
theriae biotype gravis strains sequences of the genes 
encoding 67–72p protein and structural proteins pili 
SpaI, SpaC and SapD (Table III). The sequence stability 
of these fragments represents a first step toward being 
the potential vaccine candidates. The analysis of amino 
acid sequences of these fragments confirmed that the 
proteins tested are located in the membrane or cell wall 
and have a large extracellular part (Table V).
An effective vaccine should induce a protective and 
long-lasting immune response. Therefore, we carried 
out analyses of the affinity of the tested proteins to MHC 
classes I and II and linear B-cell epitopes. MHC class I 
presents antigens to CD8+ T-cells and MHC class  II 
presents antigens to CD4+ T-cells. The antigens, which 
are recognized by CD4+ and/or CD8+ T-cell receptors, 
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have the potential to stimulate a long-lasting and cyto-
toxic immune response. B-cell epitopes can induce both 
primary and secondary immunity. We showed that, in 
each of the proteins, areas with high affinity to MHC 
receptors can be distinguished (Table VI, Table VII, 
Table VIII) and we localized B-cell epitopes from target 
proteins (Table IX). In addition, the VaxiJen server was 
used that is a reliable and consistent tool for predicting 
protective antigens of bacterial, viral and cancer origin. 
The results obtained also confirmed that the proteins 
tested by us could be interesting to use as antigens in 
vaccines (Table X).
Our studies have shown that in the genome of the 
89/E strain, the insertion element of 1380 bp was trans-
posed and attached to fragment 4 of the gene encod-
ing the SpaC pili protein. The process of transposition 
of ISs can inactivate genes (Trost et al. 2012). Mand-
lik et al. (2007) confirmed the reduced C. diphtheriae 
adhesive activity as the result of mutations at the base 
pili protein SpaB and at the tip pili protein SpaC of the 
SpaA-type pili. Premature stop codons in the continuity 
of the genes encoding the proteins responsible for the 
adhesion of bacteria to host cells inactivate them and 
limit the colonization process. We did not investigate 
the adhesive activity of the strain 89/E and, therefore, 
we can only posit the influence of the insertion on the 
adhesive properties of the strain based on the data pub-
lished by other researchers.
Due to the fact that in many European countries 
the number of infections with non-toxigenic C. diph­
theriae strains has recently increased, a key aspect of 
our research was the understanding of virulence fac-
tors other than the diphtheria toxin and identification 
of new vaccine targets. An important problem is also 
the understanding of the colonization process and in 
particular the mechanism of adhesion and structure of 
the proteins, which participate in this process. Blocking 
the 67–72p surface protein or pili structural proteins 
could effectively prevent the adhesion of C. diphtheriae 
bacteria to host tissues, colonization, and infection 
development. Due to the comparison of the nucleo-
tide sequences of the C. diphtheriae strains identifica-
tion of the most conserved sequences in the genome 
and determination of the variability between strains 
was achieved. The conserved sequences identified in 
67–72p, SpaC, SapD and SpaI in our study are iden-
tical for all C. diphtheriae strains tested and contain 
the epitopes for B-cells and T-cells and will be used in 
further research on the construction of a new vaccine. 
The main limitation of this study is the small number 
of isolates investigated. However, the results obtained 
here support further studies with a larger number of 
isolates from different countries. Moreover, the results 
of in silico analysis should be confirmed by in vivo 
studies on an animal model. The new vaccine will act 
to inactivate the antigens responsible for the host cell 
colonization by C. diphtheriae strains and inhibit the 
development of infection.
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